Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A
Open Access
- 6 January 2019
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2019, 1-10
Abstract
Background. As the malignant tumor with the highest incidence in teenagers, osteosarcoma has become a major problem in oncology research. In addition to surgical management, the pharmacotherapeutic strategy for osteosarcoma treatment is an attractive way to explore. It has been demonstrated that biochanin A has an antitumor capacity on multiple kinds of solid tumor, including osteosarcoma. But the precise mechanism of biochanin A against osteosarcoma is still needed to be discovered.Objective. To identify the potential therapeutic targets of biochanin A in treating osteosarcoma.Methods. In present study, an integrated approach including network pharmacology and molecular docking technique was conducted, which mainly comprises target prediction, network construction, gene ontology, and pathway enrichment. CCK8 test was employed to evaluate the cell viability of MG63 cells. Western-blot was used to verify the target proteins of biochanin A.Results. Ninety-six and 114 proteins were obtained as the targets of biochanin A and osteosarcoma, respectively. TP53, IGF1, JUN, BGLAP, ATM, MAPK1, ATF3, H2AFX, BAX, CDKN2A, and EGF were identified as the potential targets of biochanin A against osteosarcoma. Based on the western-blot detection, the expression of BGLAP, BAX, and ATF3 in MG63 cell line changed under the treatment of biochanin A.Conclusion. Biochanin A can effectively suppress the proliferation of osteosarcoma and regulate the expression of BGLAP, BAX, and ATF3, which may act as the potential therapeutic targets of osteosarcoma.Keywords
Funding Information
- National Natural Science Foundation of China (81860469, 81802186)
- National Natural Science Foundation of China (81860469, 81802186)
This publication has 35 references indexed in Scilit:
- Biochanin A reduces pancreatic cancer survival and progressionAnti-Cancer Drugs, 2014
- STITCH 4: integration of protein–chemical interactions with user dataNucleic Acids Research, 2013
- 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin markNature, 2013
- The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosisUrologic Oncology: Seminars and Original Investigations, 2013
- Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cellsAntiviral Research, 2013
- SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 geneJournal of Cellular Biochemistry, 2012
- p53 and MDM2 are involved in the regulation of osteocalcin gene expressionExperimental Cell Research, 2012
- Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiationStrahlentherapie und Onkologie, 2012
- GeneCards Version 3: the human gene integratorDatabase: The Journal of Biological Databases and Curation, 2010
- DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene listsNucleic Acids Research, 2007